Tag: BioNTech

BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

7 September 2026 No Comments

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present new clinical data from its

BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030

16 February 2023 No Comments

BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030

BioNTech to ship mRNA vaccine factory kits to Africa

26 April 2022 No Comments

Turnkey shipping-container factory to be set up in Africa in H2